The use of Protein-A in the treatment of malignancy: rationale and the NCi experience
Messerschmidt, G.L.; Bowles, C.; Parrillo, J.; Parker, M.; Shelhammer, J.; Dowling, R.; Osborne, L.; Corbitt, R.; McCormack, K.; Longo, D.; Deisseroth, A.
Progress in Clinical and Biological Research 106: 385-390
1982
ISSN/ISBN: 0361-7742 PMID: 6757952 Document Number: 193287
Document emailed within 1 workday
Related Documents
Matzaroglou, C.; Georgiou, C.S.; Assimakopoulos, K.; Giannakenas, C.; Karageorgos, A.; Saridis, A.; Kafchitsas, K.; Wilke, H.J. 2011: Kümmell's disease: pathophysiology, diagnosis, treatment and the role of nuclear medicine. Rationale according to our experience Hellenic Journal of Nuclear Medicine 14(3): 291-299Engelman, R.W.; Good, R.A.; Day, N.K. 1987: Clearance of retroviremia and regression of malignancy in cats with leukemia-lymphoma during treatment with staphylococcal protein a Cancer Detection and Prevention 10(5-6): 435-444
Young, G.A.; Milliken, S.; Jurd, J.; Poulgrain, P.; Vincent, P.C. 1986: The intraventricular reservoir in the treatment of neurological disease secondary to hematological malignancy: an eight year experience Australian and New Zealand Journal of Medicine 16(3): 373-377
Rahardjo, D.; Kamil, S.T.; Pakasi, L.S. 2000: Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 563-570
Fine, H.A.; Antman, K.H. 1992: High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience Bone Marrow Transplantation 10(4): 315-321
Kawano, K. 1984: An approach of immunology. Malignancy and M-protein Rinsho Byori. Japanese Journal of Clinical Pathology 32(8): 821-827
Forbes, A. 1987: Foetal steroid binding protein and malignancy Anticancer Research 7(5b): 937-941
Brock, D.J. 1982: Screening for fetal neural tube defects: rationale and experience Progress in Clinical and Biological Research 103 Pt B: 461-472
Lemieux, M.; Dumesnil, J.G.; Dowd, C.; Lutz, D.; Cartier, P.; Desaulniers, D.; Despres, J.P.; Metras, J.; Raymond, G. 1988: A new porcine bioprosthesis: design rationale and early clinical experience Canadian Journal of Cardiology 4(6): 322-327
Gustilo, R.B.; Bechtold, J.E.; Giacchetto, J.; Kyle, R.F. 1989: Rationale, experience, and results of long-stem femoral prosthesis Clinical Orthopaedics and Related Research 249: 159-168
Belsito, A.A.; Dickinson, P.B. 1973: Gastric malignancy. Gastroscopic experience Minnesota Medicine 56(10): 854-858
Venulet, J.; Ciucci, A.; Berneker, G.C. 1980: Standardized assessment of drug-adverse reaction associations--rationale and experience International Journal of Clinical Pharmacology Therapy and Toxicology 18(9): 381-388
Lorber, A. 1981: Experience and rationale of monitoring plasma levels of gold in rheumatoid arthritis Agents and Actions. Supplements 8: 539-573
Nakata, B.; Onoda, N.; Chung, Y.S.; Maeda, K.; Nishimura, S.; Yashiro, M.; Nitta, A.; Kubo, T.; Kato, Y.; Sowa, M. 1995: Correlation between malignancy of gastric cancer and c-myc DNA amplification or overexpression of c-myc protein Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(Suppl 2): 176-179
Ruangkanchanasetr, P.; Lauhawatana, B.; Leawseng, S.; Kitpanich, S.; Lumpaopong, A.; Thirakhupt, P. 2012: Malignancy in renal transplant recipients: a single-center experience in Thailand Journal of the Medical Association of Thailand 95(Suppl 5): S12-S16
Pravettoni, G.; Parisi, M.; Benedetti, U. 1980: CEA and protein determination in the acute phase in assessing the degree of malignancy of gastrointestinal tract tumors La Radiologia Medica 66(11): 847-848
Larson, R.C.; Osada, H.; Larson, T.A.; Lavenir, I.; Rabbitts, T.H. 1995: The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice Oncogene 11(5): 853-862
Onuma, E.; Sato, K.; Saito, H.; Tsunenari, T.; Ishii, K.; Esaki, K.; Yabuta, N.; Wakahara, Y.; Yamada-Okabe, H.; Ogata, E. 2004: Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy Anticancer Research 24(5a): 2665-2673
Sirichindakul, B.; Nonthasoot, B.; Thienpaitoon, P.; Nivatvongs, S.; Janchai, A. 2005: Preoperative portal vein embolization in hepatobiliary tract malignancy: an experience at King Chulalongkorn Memorial Hospital Journal of the Medical Association of Thailand 88(8): 1115-1119
Ossowski, L.; Reich, E. 1980: Loss of malignancy during serial passage of human carcinoma in culture and discordance between malignancy and transformation parameters Cancer Research 40(7): 2310-2315